Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Symbol: NKTR on Nasdaq
Shares outstanding: 20,788,527
Price per share: $42.29
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 7,254
Total reported value: $412,697
% of total 13F portfolios: 0%
Share change: +806
Value change: +$299,814
Number of holders: 8
Price from insider filings: $42.29

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) based on Schedule 13D/G filings

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
BlackRock, Inc.	6.7%	$6,138,723	12,528,006	BlackRock, Inc.	31 Mar 2025
EVENTIDE ASSET MANAGEMENT, LLC	3.6%	$3,258,500	6,650,000	Eventide Asset Management, LLC	31 Dec 2024
Deep Track Capital, LP	1.1%	$968,239	1,975,998	Deep Track Capital, LP	31 Dec 2024

As of 30 Sep 2025, 8 institutional investors reported holding 7,254 shares of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR). This represents 0.03% of the company’s total 20,788,527 outstanding shares.

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	21	$888				$42.29	1
2025 Q3	7,254	$412,697	+$299,814			$56.90	8
2025 Q2	6,448	$52,906	-$84,345,474	$0	$0	$25.84	7
2025 Q1	123,832,570	$84,191,630	-$9,619,003	$43,928	$800,887	$0.68	156
2024 Q4	132,868,565	$123,546,671	-$10,068,609	$4,557	$84,723	$0.93	144
2024 Q3	140,728,695	$182,906,396	+$5,563,274	$18,330	$42,380	$1.30	139
2024 Q2	135,417,464	$167,916,296	+$31,237,316	$68,820	$40,672	$1.24	132
2024 Q1	112,890,288	$105,437,293	-$4,221,482	$3,737	$139,298	$0.93	117
2023 Q4	61,422	$34,095	+$1,814			$0.56	2
2023 Q3	141,970,980	$84,570,298	+$3,892,301	$27,874	$4,824	$0.60	125
2023 Q2	135,710,806	$78,060,059	-$21,585,479	$34,455	$317,983	$0.58	133
2023 Q1	170,724,836	$119,779,564	-$6,894,879	$7,802	$458,876	$0.70	183
2022 Q4	168,748,536	$381,345,613	-$28,117,424	$21,696	$24,182	$2.26	204
2022 Q3	171,551,011	$549,338,990	-$30,507,862	$67,000	$333,200	$3.20	201
2022 Q2	180,682,810	$686,658,390	+$15,699,537	$332,000	$1,556,560	$3.80	200
2022 Q1	175,418,881	$945,423,233	-$13,565,570	$23,353,880	$24,343,703	$5.39	210
2021 Q4	167,154,299	$2,258,638,117	+$158,722,470	$22,919,980	$24,713,000	$13.51	223
2021 Q3	167,475,774	$3,007,401,839	-$14,768,316	$5,854,000	$20,275,000	$17.96	225
2021 Q2	167,924,322	$2,881,237,290	-$33,472,118	$9,704,000	$9,103,000	$17.16	228
2021 Q1	169,429,239	$3,387,728,860	-$52,193,852	$6,708,000	$6,979,000	$20.00	223
2020 Q4	171,917,020	$2,922,754,247	-$16,124,013	$6,732,000	$17,520,000	$17.00	222
2020 Q3	175,416,313	$2,910,329,919	-$42,134,661	$7,011,000	$12,081,000	$16.59	231
2020 Q2	174,817,804	$4,048,474,083	-$45,302,369	$14,046,000	$19,429,000	$23.16	244
2020 Q1	176,866,392	$3,158,692,057	+$47,446,931	$13,625,000	$10,579,000	$17.85	225
2019 Q4	175,227,518	$3,781,950,206	-$41,488,916	$26,198,000	$28,719,000	$21.58	265
2019 Q3	177,956,636	$3,240,939,588	+$141,041,786	$23,005,000	$27,924,000	$18.22	268
2019 Q2	164,246,857	$5,841,873,642	+$924,947,820	$60,763,000	$29,198,000	$35.58	321
2019 Q1	160,470,025	$5,390,740,799	-$79,603,007	$41,077,000	$23,155,000	$33.60	332
2018 Q4	162,946,621	$5,356,035,238	+$29,588,776	$42,838,000	$70,300,000	$32.87	317
2018 Q3	158,289,987	$9,649,145,758	-$32,251,420	$113,164,000	$190,139,000	$60.96	372
2018 Q2	160,383,418	$7,830,806,591	-$68,192,520	$93,327,000	$207,754,000	$48.83	363
2018 Q1	156,770,636	$16,651,028,196	+$336,115,493	$144,863,000	$338,635,000	$106.26	346
2017 Q4	154,230,306	$9,211,692,173	+$141,059,952	$25,287,000	$169,331,000	$59.72	258
2017 Q3	153,897,366	$3,692,333,792	+$66,232,342	$7,952,000	$32,285,000	$24.00	202
2017 Q2	151,032,771	$2,953,347,678	+$97,188,446	$8,032,000	$29,363,000	$19.55	195
2017 Q1	146,311,934	$3,432,643,057	+$471,876,697	$9,433,000	$28,677,000	$23.47	198
2016 Q4	144,999,993	$1,779,241,465	+$106,224,693	$4,733,000	$7,889,000	$12.27	193
2016 Q3	133,535,856	$2,292,233,354	-$2,551,214	$4,533,000	$4,018,000	$17.18	189
2016 Q2	134,393,493	$1,912,184,366	-$65,595,693	$2,159,000	$2,498,000	$14.23	171
2016 Q1	138,872,787	$1,909,523,245	-$10,625,320	$2,874,000	$3,119,000	$13.75	170
2015 Q4	139,453,936	$2,349,674,705	-$21,062,773	$3,892,000	$4,917,000	$16.85	176
2015 Q3	140,261,269	$1,537,189,761	+$32,316,870	$3,052,000	$3,120,000	$10.96	161
2015 Q2	136,760,070	$1,710,429,850	+$152,914,470	$4,111,000	$4,956,000	$12.51	178
2015 Q1	125,532,132	$1,380,922,636	+$59,992,646	$4,723,000	$8,984,000	$11.00	150
2014 Q4	120,120,654	$1,861,694,087	+$32,166,191	$1,958,000	$3,625,000	$15.50	162
2014 Q3	118,403,758	$1,429,229,131	+$50,407,399	$1,881,000	$10,030,000	$12.07	144
2014 Q2	114,171,023	$1,463,210,133	-$20,565,583	$3,500,000	$16,627,000	$12.82	140
2014 Q1	115,187,825	$1,395,722,024	+$164,445,280	$2,885,000	$6,657,000	$12.12	139